These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4353792)

  • 21. Genetic marker studies on poliovirus type 1 strains from the Blackburn poliomyelitis outbreak in 1965.
    Cossart YE
    J Hyg (Lond); 1968 Dec; 66(4):513-8. PubMed ID: 4303952
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of a microtechnic for the serological intratype identification of poliovirus strains 1 and 3].
    Stewien KE; Lacerda JP
    Rev Saude Publica; 1977 Mar; 11(1):135-42. PubMed ID: 193175
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic markers and serological identity of wild and attenuated strains of type-1 poliovirus, with special emphasis on strains isolated from patients during an epidemic in the Belgian Congo.
    KOPROWSKI H; NORTON TW; WECKER E; GARD S
    Bull World Health Organ; 1960; 22(3-4):243-53. PubMed ID: 14410972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of poliovirus infection in laboratory animals of different species].
    Koroleva GA; Lashkevich VA; Voroshilova MK
    Vopr Virusol; 1975; (4):445-9. PubMed ID: 175580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratypic serodifferentiation of poliovirus type 1 isolates using kinetic neutralization test.
    Deshpande JM; Dave KH
    Indian J Med Res; 1987 Oct; 86():419-22. PubMed ID: 2832324
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavior of poliovirus strains of different virulence under solid overlays.
    Balayan MS; Voroshilova MK; Sinyak LI; Chumakova AB
    Arch Gesamte Virusforsch; 1970; 32(4):299-310. PubMed ID: 4322846
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
    Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
    Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratypic differentiation of poliovirus strains of type I from pre- and post-vaccination groups.
    Sevani HK; Gharpure PV
    Indian J Med Res; 1969 Sep; 57(9):1591-606. PubMed ID: 4313048
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of type 1 poliovirus by electrophoretic analysis.
    Mandel B
    Virology; 1971 Jun; 44(3):554-68. PubMed ID: 4332969
    [No Abstract]   [Full Text] [Related]  

  • 30. [Distribution and characteristics of poliovirus strains circulating in Poland in 1968-1972. II. Genetic characteristics of strains isolated during the 1968 poliomyelitis epidemic, from sporadic cases and from sewage].
    Kańtoch M; Dobrowolska H; Jarzabek Z; Jankowski M
    Med Dosw Mikrobiol; 1975; 27(4):365-71. PubMed ID: 175225
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on strains of poliomyelitis virus isolated in Poland during the 1959-1965 period. 3. Characteristics of strains isolated following the vaccination activities].
    Dobrowolska H
    Med Dosw Mikrobiol; 1966; 18(4):397-404. PubMed ID: 4289231
    [No Abstract]   [Full Text] [Related]  

  • 33. [Characterization of vaccine polioviruses isolated in the closed pediatric collective bodies (children's homes)].
    Romanenkova NI; Bichurina MA; Rozaeva NR
    Vopr Virusol; 2010; 55(2):42-5. PubMed ID: 20455472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Characteristics of intracellular virus-specific structures].
    Sadogurskaia EM; Gorshunova LP; Kiselev FL
    Vopr Virusol; 1977; (2):189-92. PubMed ID: 197714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mutagenic action of proflavine on type 3 poliovirus.
    Pervikov YV; Vorohsilova MK; Chumakov MP; Savinov AP; Yurovetskaya AL
    Acta Virol; 1973 Jul; 17(4):365. PubMed ID: 4148222
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the characteristics of Poliovirus type 3. III. Strain characteristics after passage in man.
    Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
    Acta Virol; 1976 Oct; 20(5):373-9. PubMed ID: 11664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 39. DETECTION OF POLIOVIRUS TYPE 1 IN HUMAN CEREBROSPINAL FLUID.
    WRIGHT HT; WARD R
    J Pediatr; 1965 Mar; 66():489-94. PubMed ID: 14264307
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.